Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for enhancing immunity

A composition and immunoregulatory technology, applied in the direction of drug combination, effective ingredients of hydroxyl compounds, active ingredients of heterocyclic compounds, etc., can solve the problems of unavailability, insufficient supply, high cost, etc.

Inactive Publication Date: 2016-05-04
ACTIGENOMICS
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0030] Despite a large number of specific treatments, therapies, prophylaxis and prevention, the large number of deaths due to infectious diseases shows that these measures when they are most needed - due to various reasons such as insufficient supply, high cost, for most Individuals are inefficient or unavailable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for enhancing immunity
  • Composition for enhancing immunity
  • Composition for enhancing immunity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 3

[0217] With respect to Example 3, inflammation is mediated by an imbalance between affinity anti-inflammatory immune control molecules called cytokines. Among them, interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) are pro-inflammatory factors. TNF-α在许多免疫介导的炎性疾病中发挥关键作用(TCantaert,DBaeten,PPTakandLGMvanBaarsen,TypeIIFNandTNFαcross-regulationinimmune-mediatedinflammatorydisease:basicconceptsandclinicalrelevance.ArthritisResearch&Therapy2010,12:219;Cytokinesandtheirrelationshiptothesymptomsandoutcomeofcancer.BSeruga,HZhang,LBernstein&IFTannock,NatureReviewsCancer2008,8,887)。

Embodiment 4

[0218] For Example 4, pathogenic influenza virus infection can induce robust cytokine production, excessive inflammatory infiltration, and virus-induced tissue destruction, which contribute to morbidity and mortality ((JRTeijaroa, KBWalsha, SRicea, HRosenandMBAOldstone, ProcNatlAcadSciUSA. 2014 Mar 11; 111(10): 3799-804).

Embodiment 2

[0219] With regard to Example 2, decreased lung function correlates with increased levels of systemic inflammatory markers, which may have important pathophysiological and therapeutic implications for subjects with stable COPD (MMiravita, MCalleb, JJSoler- Clinical Phenotypes of COPD: Identification, Definition and Implications for Guidelines. Arch Broncopneumol. 2012; 48, 3: 86-98).

[0220] In a further aspect there is provided the use of the immunomodulatory and / or stimulating composition of the invention in a method for enhancing the immune response to an antigenic protein during vaccination.

[0221] It has also been shown that the compositions of the present invention can be used to enhance the immune response to vaccines and contribute to better vaccine-mediated disease prevention.

[0222] "Vaccination" (immunization) is a method of triggering an immune response. Small doses of antigens, such as inactivated or weakened live viruses, are used to activate the immune sy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to preparations for dietary, food supplement or medical purposes and more specifically to a safe and natural preparation or a composition useful in immunity regulation and / or stimulation and in particular in the building, reinforcement, efficiency, maintenance and regeneration of natural immune defences in a subject. The preparations comprise magnesium, zinc and / or iron, blackcurrent seed oil and / or palm oil, two plant extracts selected from thyme, chickpea and lentil, as well as algae (fucus, wakame, nori), mushroom (shiitake, maitake), and at least one hydrosoluble vitamin and / or vitamin E.

Description

technical field [0001] The present invention relates to formulations for dietary, food supplement or medicinal purposes, and more particularly to a formulation comprising the most effective and useful for immunomodulation and / or stimulation, designed together in terms of optimizing general health and enhancing immunity. A safe and natural preparation or composition of a combination of natural supplements. Specifically, the composition can provide for the construction, enhancement, synergy, maintenance and regeneration of the natural immune defense of the subject, and is also beneficial to the improvement of sub-health conditions without side effects. Background technique [0002] immune system [0003] The immune system is a complex and dynamic network of cells, cell membranes, organs, circulatory system and many other components that all work together to recognize, attack and destroy microorganisms, bacteria, viruses, fungi and parasites that cause infection and disease. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/10A23L33/15A23L33/155A23L33/16A61K33/06A61K33/26A61K33/30A61K36/03A61K36/07A61K36/185A61K36/53
CPCA23L2/52A61K33/06A61K33/26A61K36/03A61K36/07A61K36/185A61K36/53A61K36/889A61K36/04A61K36/48A61K36/60A61K45/06A61K31/07A61K31/164A61K31/355A61K31/375A61K31/4415A61K31/455A61K31/51A61K31/519A61K31/525A23L33/105A23L33/12A23L33/15A23L33/155A23L33/16A61K33/30A23V2002/00A61K31/191A61K31/675A61K33/00A61P1/00A61P11/00A61P13/02A61P17/00A61P27/16A61P29/00A61P3/02A61P31/04A61P31/06A61P31/10A61P31/12A61P31/18A61P33/00A61P37/02A61P37/04A61P43/00Y02A50/30A23V2250/1592A23V2250/161A23V2250/1642A23V2250/18A23V2250/208A23V2250/21A23V2250/702A23V2250/7042A23V2250/7044A23V2250/7046A23V2250/705A23V2250/7052A23V2250/7058A23V2250/708A23V2250/712A61K2300/00
Inventor 玛丽·弗朗索瓦·布尔乔亚丹尼尔·塞菲瓦尔特·瓦利米雷耶·普林斯·大卫李斯恩·崔圣吉
Owner ACTIGENOMICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products